Bioavailability intelligence, grounded in PK

Supplement intelligence that shows where the evidence holds — and where it doesn’t.

Availabio helps individuals and brand teams check formulation assumptions, review interaction context, and understand evidence strength before making decisions.

PK outputs are model-derived estimates for educational and formulation intelligence use only. Not clinical or legal advice.

529
CYP pathwaysmetabolic route coverage
28
curated compoundssource-verified parameters
IVIVE
IVIVE-informed PK simulationextrapolation method
A/B/C/D
evidence gradesper parameter, every output

Two different uses. One evidence layer.

Availabio covers two separate use cases. Choose the one that describes your situation.

For brands

Formulation intelligence for product and R&D teams

Check bioavailability differences between delivery formats, review CYP interaction assumptions, and distinguish well-supported estimates from early-stage hypotheses — before committing to a formulation direction or writing a product brief.

For you

Supplement context for individuals

Review your supplement stack, check timing and food-context questions, see interaction assumptions, and understand what the evidence behind a compound actually shows — including where it is weak or missing.

Educational and formulation intelligence use only. PK simulation outputs are model-derived estimates informed by IVIVE methodology. Outputs are not clinical advice, not legal advice, and not intended for regulatory submission.